Global Drug based on CAR T-Cell Market Growth (Status and Outlook) 2022-2028
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The global market for Drug based on CAR T-Cell is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Drug based on CAR T-Cell market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Drug based on CAR T-Cell market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Drug based on CAR T-Cell market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Drug based on CAR T-Cell market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Drug based on CAR T-Cell players cover Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J and JW Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Drug based on CAR T-Cell market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Drug based on CAR T-Cell market, with both quantitative and qualitative data, to help readers understand how the Drug based on CAR T-Cell market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Drug based on CAR T-Cell market and forecasts the market size by Type (CD19-targeted and BCMA-targeted,), by Application (Lymphoma and Multiple Myeloma.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
CD19-targeted
BCMA-targeted
Segmentation by application
Lymphoma
Multiple Myeloma
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Chapter Introduction
Chapter 1: Scope of Drug based on CAR T-Cell, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug based on CAR T-Cell market size and CAGR, Drug based on CAR T-Cell market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug based on CAR T-Cell revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug based on CAR T-Cell revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug based on CAR T-Cell market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), CARsgen Therapeutics and Autolus Therapeutics, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug based on CAR T-Cell Market Size 2017-2028
2.1.2 Drug based on CAR T-Cell Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drug based on CAR T-Cell Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.3 Drug based on CAR T-Cell Market Size by Type
2.3.1 Drug based on CAR T-Cell Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
2.4 Drug based on CAR T-Cell Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 Drug based on CAR T-Cell Market Size by Application
2.5.1 Drug based on CAR T-Cell Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
3 Drug based on CAR T-Cell Market Size by Player
3.1 Drug based on CAR T-Cell Market Size Market Share by Players
3.1.1 Global Drug based on CAR T-Cell Revenue by Players (2020-2022)
3.1.2 Global Drug based on CAR T-Cell Revenue Market Share by Players (2020-2022)
3.2 Global Drug based on CAR T-Cell Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug based on CAR T-Cell by Regions
4.1 Drug based on CAR T-Cell Market Size by Regions (2017-2022)
4.2 Americas Drug based on CAR T-Cell Market Size Growth (2017-2022)
4.3 APAC Drug based on CAR T-Cell Market Size Growth (2017-2022)
4.4 Europe Drug based on CAR T-Cell Market Size Growth (2017-2022)
4.5 Middle East & Africa Drug based on CAR T-Cell Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drug based on CAR T-Cell Market Size by Country (2017-2022)
5.2 Americas Drug based on CAR T-Cell Market Size by Type (2017-2022)
5.3 Americas Drug based on CAR T-Cell Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug based on CAR T-Cell Market Size by Region (2017-2022)
6.2 APAC Drug based on CAR T-Cell Market Size by Type (2017-2022)
6.3 APAC Drug based on CAR T-Cell Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug based on CAR T-Cell by Country (2017-2022)
7.2 Europe Drug based on CAR T-Cell Market Size by Type (2017-2022)
7.3 Europe Drug based on CAR T-Cell Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug based on CAR T-Cell by Region (2017-2022)
8.2 Middle East & Africa Drug based on CAR T-Cell Market Size by Type (2017-2022)
8.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug based on CAR T-Cell Market Forecast
10.1 Global Drug based on CAR T-Cell Forecast by Regions (2023-2028)
10.1.1 Global Drug based on CAR T-Cell Forecast by Regions (2023-2028)
10.1.2 Americas Drug based on CAR T-Cell Forecast
10.1.3 APAC Drug based on CAR T-Cell Forecast
10.1.4 Europe Drug based on CAR T-Cell Forecast
10.1.5 Middle East & Africa Drug based on CAR T-Cell Forecast
10.2 Americas Drug based on CAR T-Cell Forecast by Country (2023-2028)
10.2.1 United States Drug based on CAR T-Cell Market Forecast
10.2.2 Canada Drug based on CAR T-Cell Market Forecast
10.2.3 Mexico Drug based on CAR T-Cell Market Forecast
10.2.4 Brazil Drug based on CAR T-Cell Market Forecast
10.3 APAC Drug based on CAR T-Cell Forecast by Region (2023-2028)
10.3.1 China Drug based on CAR T-Cell Market Forecast
10.3.2 Japan Drug based on CAR T-Cell Market Forecast
10.3.3 Korea Drug based on CAR T-Cell Market Forecast
10.3.4 Southeast Asia Drug based on CAR T-Cell Market Forecast
10.3.5 India Drug based on CAR T-Cell Market Forecast
10.3.6 Australia Drug based on CAR T-Cell Market Forecast
10.4 Europe Drug based on CAR T-Cell Forecast by Country (2023-2028)
10.4.1 Germany Drug based on CAR T-Cell Market Forecast
10.4.2 France Drug based on CAR T-Cell Market Forecast
10.4.3 UK Drug based on CAR T-Cell Market Forecast
10.4.4 Italy Drug based on CAR T-Cell Market Forecast
10.4.5 Russia Drug based on CAR T-Cell Market Forecast
10.5 Middle East & Africa Drug based on CAR T-Cell Forecast by Region (2023-2028)
10.5.1 Egypt Drug based on CAR T-Cell Market Forecast
10.5.2 South Africa Drug based on CAR T-Cell Market Forecast
10.5.3 Israel Drug based on CAR T-Cell Market Forecast
10.5.4 Turkey Drug based on CAR T-Cell Market Forecast
10.5.5 GCC Countries Drug based on CAR T-Cell Market Forecast
10.6 Global Drug based on CAR T-Cell Forecast by Type (2023-2028)
10.7 Global Drug based on CAR T-Cell Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Drug based on CAR T-Cell Product Offered
11.1.3 Novartis Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Drug based on CAR T-Cell Product Offered
11.2.3 Gilead Sciences Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Drug based on CAR T-Cell Product Offered
11.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J Drug based on CAR T-Cell Product Offered
11.4.3 J & J Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics Drug based on CAR T-Cell Product Offered
11.5.3 JW Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite Drug based on CAR T-Cell Product Offered
11.6.3 FOSUNKite Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Information
11.7.2 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Offered
11.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 CARsgen Therapeutics (Pipeline) Main Business Overview
11.7.5 CARsgen Therapeutics (Pipeline) Latest Developments
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Information
11.8.2 CARsgen Therapeutics Drug based on CAR T-Cell Product Offered
11.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 CARsgen Therapeutics Main Business Overview
11.8.5 CARsgen Therapeutics Latest Developments
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Information
11.9.2 Autolus Therapeutics Drug based on CAR T-Cell Product Offered
11.9.3 Autolus Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Autolus Therapeutics Main Business Overview
11.9.5 Autolus Therapeutics Latest Developments
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Information
11.10.2 Sorrento Therapeutics Drug based on CAR T-Cell Product Offered
11.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Sorrento Therapeutics Main Business Overview
11.10.5 Sorrento Therapeutics Latest Developments
11.11 Mustang Bio
11.11.1 Mustang Bio Company Information
11.11.2 Mustang Bio Drug based on CAR T-Cell Product Offered
11.11.3 Mustang Bio Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Mustang Bio Main Business Overview
11.11.5 Mustang Bio Latest Developments
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Information
11.12.2 Bluebird Bio Drug based on CAR T-Cell Product Offered
11.12.3 Bluebird Bio Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bluebird Bio Main Business Overview
11.12.5 Bluebird Bio Latest Developments
11.13 Cellectis
11.13.1 Cellectis Company Information
11.13.2 Cellectis Drug based on CAR T-Cell Product Offered
11.13.3 Cellectis Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Cellectis Main Business Overview
11.13.5 Cellectis Latest Developments
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Information
11.14.2 Allogene Therapeutics Drug based on CAR T-Cell Product Offered
11.14.3 Allogene Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Allogene Therapeutics Main Business Overview
11.14.5 Allogene Therapeutics Latest Developments
11.15 Celyad
11.15.1 Celyad Company Information
11.15.2 Celyad Drug based on CAR T-Cell Product Offered
11.15.3 Celyad Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Celyad Main Business Overview
11.15.5 Celyad Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Drug based on CAR T-Cell Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CD19-targeted
Table 3. Major Players of BCMA-targeted
Table 4. Drug based on CAR T-Cell Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
Table 7. Drug based on CAR T-Cell Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
Table 10. Global Drug based on CAR T-Cell Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Drug based on CAR T-Cell Revenue Market Share by Player (2020-2022)
Table 12. Drug based on CAR T-Cell Key Players Head office and Products Offered
Table 13. Drug based on CAR T-Cell Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug based on CAR T-Cell Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Drug based on CAR T-Cell Market Size Market Share by Regions (2017-2022)
Table 18. Americas Drug based on CAR T-Cell Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Drug based on CAR T-Cell Market Size Market Share by Country (2017-2022)
Table 20. Americas Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
Table 22. Americas Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
Table 24. APAC Drug based on CAR T-Cell Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Drug based on CAR T-Cell Market Size Market Share by Region (2017-2022)
Table 26. APAC Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
Table 28. APAC Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
Table 30. Europe Drug based on CAR T-Cell Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Drug based on CAR T-Cell Market Size Market Share by Country (2017-2022)
Table 32. Europe Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
Table 34. Europe Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Drug based on CAR T-Cell Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Drug based on CAR T-Cell Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Drug based on CAR T-Cell Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Drug based on CAR T-Cell
Table 43. Key Market Challenges & Risks of Drug based on CAR T-Cell
Table 44. Key Industry Trends of Drug based on CAR T-Cell
Table 45. Global Drug based on CAR T-Cell Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Drug based on CAR T-Cell Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Drug based on CAR T-Cell Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Drug based on CAR T-Cell Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Drug based on CAR T-Cell Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Drug based on CAR T-Cell Market Size Market Share Forecast by Application (2023-2028)
Table 51. Novartis Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 52. Novartis Drug based on CAR T-Cell Product Offered
Table 53. Novartis Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments
Table 56. Gilead Sciences Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 57. Gilead Sciences Drug based on CAR T-Cell Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Gilead Sciences Latest Developments
Table 61. Bristol-Myers Squibb Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 62. Bristol-Myers Squibb Drug based on CAR T-Cell Product Offered
Table 63. Bristol-Myers Squibb Main Business
Table 64. Bristol-Myers Squibb Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Bristol-Myers Squibb Latest Developments
Table 66. J & J Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 67. J & J Drug based on CAR T-Cell Product Offered
Table 68. J & J Main Business
Table 69. J & J Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. J & J Latest Developments
Table 71. JW Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 72. JW Therapeutics Drug based on CAR T-Cell Product Offered
Table 73. JW Therapeutics Main Business
Table 74. JW Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. JW Therapeutics Latest Developments
Table 76. FOSUNKite Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 77. FOSUNKite Drug based on CAR T-Cell Product Offered
Table 78. FOSUNKite Main Business
Table 79. FOSUNKite Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. FOSUNKite Latest Developments
Table 81. CARsgen Therapeutics (Pipeline) Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 82. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Offered
Table 83. CARsgen Therapeutics (Pipeline) Main Business
Table 84. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. CARsgen Therapeutics (Pipeline) Latest Developments
Table 86. CARsgen Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 87. CARsgen Therapeutics Drug based on CAR T-Cell Product Offered
Table 88. CARsgen Therapeutics Main Business
Table 89. CARsgen Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. CARsgen Therapeutics Latest Developments
Table 91. Autolus Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 92. Autolus Therapeutics Drug based on CAR T-Cell Product Offered
Table 93. Autolus Therapeutics Main Business
Table 94. Autolus Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Autolus Therapeutics Latest Developments
Table 96. Sorrento Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 97. Sorrento Therapeutics Drug based on CAR T-Cell Product Offered
Table 98. Sorrento Therapeutics Main Business
Table 99. Sorrento Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Sorrento Therapeutics Latest Developments
Table 101. Mustang Bio Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 102. Mustang Bio Drug based on CAR T-Cell Product Offered
Table 103. Mustang Bio Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Mustang Bio Main Business
Table 105. Mustang Bio Latest Developments
Table 106. Bluebird Bio Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 107. Bluebird Bio Drug based on CAR T-Cell Product Offered
Table 108. Bluebird Bio Main Business
Table 109. Bluebird Bio Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Bluebird Bio Latest Developments
Table 111. Cellectis Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 112. Cellectis Drug based on CAR T-Cell Product Offered
Table 113. Cellectis Main Business
Table 114. Cellectis Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Cellectis Latest Developments
Table 116. Allogene Therapeutics Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 117. Allogene Therapeutics Drug based on CAR T-Cell Product Offered
Table 118. Allogene Therapeutics Main Business
Table 119. Allogene Therapeutics Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Allogene Therapeutics Latest Developments
Table 121. Celyad Details, Company Type, Drug based on CAR T-Cell Area Served and Its Competitors
Table 122. Celyad Drug based on CAR T-Cell Product Offered
Table 123. Celyad Main Business
Table 124. Celyad Drug based on CAR T-Cell Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Celyad Latest Developments
List of Figures
List of Figures
Figure 1. Drug based on CAR T-Cell Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug based on CAR T-Cell Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drug based on CAR T-Cell Market Size Market Share by Type in 2021
Figure 7. Drug based on CAR T-Cell in Lymphoma
Figure 8. Global Drug based on CAR T-Cell Market: Lymphoma (2017-2022) & ($ Millions)
Figure 9. Drug based on CAR T-Cell in Multiple Myeloma
Figure 10. Global Drug based on CAR T-Cell Market: Multiple Myeloma (2017-2022) & ($ Millions)
Figure 11. Global Drug based on CAR T-Cell Market Size Market Share by Application in 2021
Figure 12. Global Drug based on CAR T-Cell Revenue Market Share by Player in 2021
Figure 13. Global Drug based on CAR T-Cell Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Drug based on CAR T-Cell Market Size 2017-2022 ($ Millions)
Figure 15. APAC Drug based on CAR T-Cell Market Size 2017-2022 ($ Millions)
Figure 16. Europe Drug based on CAR T-Cell Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Drug based on CAR T-Cell Market Size 2017-2022 ($ Millions)
Figure 18. Americas Drug based on CAR T-Cell Value Market Share by Country in 2021
Figure 19. Americas Drug based on CAR T-Cell Consumption Market Share by Type in 2021
Figure 20. Americas Drug based on CAR T-Cell Market Size Market Share by Application in 2021
Figure 21. United States Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Drug based on CAR T-Cell Market Size Market Share by Region in 2021
Figure 26. APAC Drug based on CAR T-Cell Market Size Market Share by Application in 2021
Figure 27. China Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Drug based on CAR T-Cell Market Size Market Share by Country in 2021
Figure 34. Europe Drug based on CAR T-Cell Market Size Market Share by Type in 2021
Figure 35. Europe Drug based on CAR T-Cell Market Size Market Share by Application in 2021
Figure 36. Germany Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Drug based on CAR T-Cell Market Size Market Share by Application in 2021
Figure 44. Egypt Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Drug based on CAR T-Cell Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 50. APAC Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 51. Europe Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 53. United States Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 54. Canada Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 57. China Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 58. Japan Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 59. Korea Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 61. India Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 62. Australia Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 63. Germany Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 64. France Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 65. UK Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 66. Italy Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 67. Russia Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 68. Spain Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 71. Israel Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Drug based on CAR T-Cell Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets